News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioxel Pharma (BIP.V) Announces Changes to its Management Team


4/30/2008 10:53:17 AM

SAINTE-FOY, QUEBEC--(Marketwire - April 29, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs,, today announced the departure of Pascal Delmas as President and Chief Executive Officer and as a Board member, as well as the appointment of Thomas Warden as Vice-President, Sales, Marketing and Regulatory Affairs. The departure of Mr. Delmas will be effective as of May 30, while the appointment of Mr. Warden is effective as of today.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES